{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:27:44Z","timestamp":1791343664012,"version":"4.3.1"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1097\/psy.0b013e31817ae69f","type":"journal-article","created":{"date-parts":[[2008,6,9]],"date-time":"2008-06-09T18:18:07Z","timestamp":1213035487000},"page":"523-530","source":"Crossref","is-referenced-by-count":58,"title":["Overview of HIV"],"prefix":"10.1097","volume":"70","author":[{"given":"Nancy","family":"Klimas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne O\u2019Brien","family":"Koneru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-2-20210213","first-page":"313","article-title":"Chimpanzee reservoirs of pandemic and nonpandemic HIV-1.","volume":"28","author":"Keele","year":"2006","journal-title":"Science"},{"key":"R3-2-20210213","first-page":"166","article-title":"Serologic evidence of human immunodeficiency virus (HIV) infection in Cuban immigrants in 1980.","volume":"2","author":"DeMedina","year":"1987","journal-title":"Lancet"},{"key":"R5-2-20210213","first-page":"565","article-title":"Early immune activation in gut-associated and peripheral lymphoid tissue during acute HIV infection.","volume":"21","author":"Nilsson","year":"12","journal-title":"AIDS 2007 Mar"},{"key":"R6-2-20210213","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/154407370601900104","article-title":"HIV pathogenesis: knowledge gained after two decades of research.","volume":"19","author":"Levy","year":"2006","journal-title":"Adv Dent Res"},{"key":"R7-2-20210213","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/QAD.0b013e3282f2589b","article-title":"The role of the thymus in HIV infection: a 10 year perspective.","volume":"22","author":"Ho Tsong Fang","year":"2008","journal-title":"AIDS"},{"key":"R8-2-20210213","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.17.1.657","article-title":"Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism and disease.","volume":"17","author":"Berger","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"R9-2-20210213","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJM199001183220305","article-title":"The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.","volume":"322","author":"Fahey","year":"1990","journal-title":"N Eng J Med"},{"key":"R13-2-20210213","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/09540120500471861","article-title":"Epidemiology of health and vulnerability among children orphaned and made vulnerable by HIV\/AIDS in sub-Saharan Africa.","volume":"18","author":"Andrews","year":"2006","journal-title":"AIDS Care"},{"key":"R18-2-20210213","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/157016207779316297","article-title":"HIV genetic diversity: biological and public health consequences.","volume":"5","author":"Butler","year":"2007","journal-title":"Curr HIV Res"},{"key":"R19-2-20210213","first-page":"75","article-title":"HIV diversity, recombination and disease progression: how does fitness \u201cfit\u201d into the puzzle?","volume":"9","author":"Tebit","year":"2007","journal-title":"AIDS Rev"},{"key":"R20-2-20210213","doi-asserted-by":"crossref","first-page":"10209","DOI":"10.1128\/JVI.00872-07","article-title":"Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications.","volume":"81","author":"Buonaguro","year":"2007","journal-title":"J Virol"},{"key":"R22-2-20210213","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/317366a0","article-title":"Nucleotide sequence evidence for relationship of AIDS retrovirus to lentiviruses.","volume":"317","author":"Chiu","year":"1985","journal-title":"Nature"},{"key":"R23-2-20210213","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/cb600131q","article-title":"Following the path of the virus: the exploitation of host DNA repair mechanisms by retroviruses.","volume":"1","author":"Smith","year":"2006","journal-title":"ACS Chem Biol"},{"key":"R24-2-20210213","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.imlet.2004.11.026","article-title":"Newly identified host factors modulate HIV replication.","volume":"97","author":"Zheng","year":"2005","journal-title":"Immunol Lett"},{"key":"R26-2-20210213","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/314660","article-title":"Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.","volume":"179","author":"Giorgi","year":"1999","journal-title":"J Infect Dis"},{"key":"R27-2-20210213","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1146\/annurev.med.53.082901.104024","article-title":"The challenge of viral reservoirs in HIV-1 infection.","volume":"53","author":"Blankson","year":"2002","journal-title":"Annu Rev Med"},{"key":"R28-2-20210213","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1749-6632.1994.tb23099.x","article-title":"Prolonged asymptomatic states in HIV-seropositive persons with fewer than 50 CD4+ T cells per mm3. Psychoneuroimmunologic findings.","volume":"741","author":"Solomon","year":"1994","journal-title":"Ann NY Acad Sci"},{"key":"R29-2-20210213","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1182\/blood.V80.3.831.831","article-title":"Effect of age on HIV-1 induced changes in lymphocytes populations among persons with congenital clotting disorders.","volume":"80","author":"Fletcher","year":"1992","journal-title":"Blood"},{"key":"R30-2-20210213","article-title":"Encyclopedia of Stress. 2nd ed.","author":"Fletcher","year":"2007"},{"key":"R31-2-20210213","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1089\/aid.1996.12.1053","article-title":"Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection.","volume":"12","author":"Clerici","year":"1996","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R32-2-20210213","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1530-0277.2007.00381.x","article-title":"Impact of hepatitis C on HIV progression in adults with alcohol problems.","volume":"31","author":"Cheng","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"key":"R33-2-20210213","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.288.2.199","article-title":"Hepatitis C and progression of HIV disease.","volume":"288","author":"Sulkowski","year":"2002","journal-title":"JAMA"},{"key":"R34-2-20210213","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/PSY.0b013e3181773bce","article-title":"Co-occurrence of treatment nonadherence and continued HIV transmission risk behaviors: implications for positive prevention interventions.","volume":"70","author":"Kalichman","year":"2008","journal-title":"Psychosom Med"},{"key":"R35-2-20210213","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/PSY.0b013e318177216c","article-title":"Do positive psychosocial factors predict disease progression in HIV? A review of the evidence.","volume":"70","author":"Ironson","year":"2008","journal-title":"Psychosom Med"},{"key":"R36-2-20210213","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/PSY.0b013e3181777a5f","article-title":"Role of depression, stress, and trauma in HIV disease progression.","volume":"70","author":"Leserman","year":"2008","journal-title":"Psychosom Med"},{"key":"R37-2-20210213","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/PSY.0b013e318177354f","article-title":"Coping as a multisystem construct associated with pathways mediating HIV-relevant immune function and disease progression.","volume":"70","author":"Temoshok","year":"2008","journal-title":"Psychosom Med"},{"key":"R38-2-20210213","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2174\/157016206776055020","article-title":"Viral piracy: HIV-1 targets dendritic cells for transmission.","volume":"4","author":"Lekkerkerker","year":"2006","journal-title":"Curr HIV Res"},{"key":"R39-2-20210213","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/bmj.313.7053.341","article-title":"Fluctuations of HIV load in semen of HIV positive patients with newly acquired sexually transmitted diseases.","volume":"313","author":"Atkins","year":"1996","journal-title":"BMJ"},{"key":"R41-2-20210213","first-page":"3","article-title":"SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria.","volume":"23","author":"Feldblum","year":"2008","journal-title":"PLoS ONE"},{"key":"R43-2-20210213","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2105\/AJPH.80.2.150","article-title":"HIV seropositivity of needles from shooting galleries in south Florida.","volume":"80","author":"Chitwood","year":"1990","journal-title":"Am J Public Health"},{"key":"R44-2-20210213","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/PSY.0b013e3181772157","article-title":"HIV prevention for injecting drug users: the first 25 years and counting.","volume":"70","author":"Des Jarlais","year":"2008","journal-title":"Psychosom Med"},{"key":"R45-2-20210213","doi-asserted-by":"crossref","first-page":"733","DOI":"10.7326\/0003-4819-113-10-733","article-title":"Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations.","volume":"113","author":"Donegan","year":"1990","journal-title":"Ann Intern Med"},{"key":"R46-2-20210213","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJMe048128","article-title":"Antiretroviral agents\u2014how best to protect infants from HIV and save their mothers from AIDS.","volume":"351","author":"Coovadia","year":"2004","journal-title":"N Engl J Med"},{"key":"R47-2-20210213","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/000313480707300701","article-title":"Occupational risks of blood exposure in the operating room.","volume":"73","author":"Fry","year":"2007","journal-title":"Am Surg"},{"key":"R50-2-20210213","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1089\/aid.2006.0301","article-title":"Detection of emerging HIV variants in blood donors from urban areas of Cameroon.","volume":"23","author":"Lee","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R51-2-20210213","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11908-006-0008-6","article-title":"A rapid review of rapid HIV antibody tests.","volume":"8","author":"Greenwald","year":"2006","journal-title":"Curr Infect Dis Rep"},{"key":"R54-2-20210213","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/187153007782794362","article-title":"HIV-therapy associated lipodystrophy: experimental and clinical evidence for the pathogenesis and treatment.","volume":"7","author":"Stankov","year":"2007","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"R55-2-20210213","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/0145445504272604","article-title":"Development and Implementation of a medication adherence training instrument for persons living with HIV: the MATI.","volume":"29","author":"McPherson-Baker","year":"2005","journal-title":"Behav Modif"},{"key":"R56-2-20210213","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2249.2006.03147.x","article-title":"Highly active anti-retroviral therapy (HAART)-induced maintenance of adaptive but not innate immune parameters is associated with protection from HIV-induced mortality.","volume":"145","author":"Stebbing","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"R57-2-20210213","first-page":"160","article-title":"Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study.","volume":"24","author":"Paredes","year":"2000","journal-title":"Arch Intern Med"},{"key":"R58-2-20210213","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1615\/JEnvPathToxOncol.v22.i3.40","article-title":"Human immunodeficiency virus type 1 pharmacogenenoics in clinical practice: relevance of HIV-1 drug resistance testing (part 1).","volume":"22","author":"Patarca","year":"2003","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"R59-2-20210213","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1615\/JEnvPathToxOncol.v22.i4.10","article-title":"Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: Relevance of HIV-1 drug resistance testing (part 2).","volume":"22","author":"Patarca","year":"2003","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"R61-2-20210213","first-page":"41","article-title":"Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis.","volume":"1","author":"Sax","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R62-2-20210213","first-page":"7","article-title":"Modelling the evolution of drug resistance in the presence of antiviral drugs.","volume":"23","author":"Wu","year":"2007","journal-title":"BMC Public Health"},{"key":"R63-2-20210213","article-title":"Adherence rates to anti-retroviral therapy in an urban tertiary care center. AIDS\/HIV Management Conference","author":"Klimas","year":"1998"},{"key":"R64-2-20210213","first-page":"358","article-title":"Disease progression, adherence and response to protease inhibitor therapy of human immunodeficiency virus infection in an urban veterans affairs medical center.","volume":"22","author":"Maher","year":"1999","journal-title":"JAIDS"},{"key":"R65-2-20210213","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1097\/QAD.0b013e3281532b31","article-title":"Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.","volume":"21","author":"Braithwaite","year":"2007","journal-title":"AIDS"},{"key":"R66-2-20210213","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(05)67395-3","article-title":"The end or the beginning of the drive to an HIV-preventive vaccine: a view from over 20 years.","volume":"366","author":"Gallo","year":"2005","journal-title":"Lancet"},{"key":"R69-2-20210213","first-page":"205:7","article-title":"The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?","volume":"21","author":"Sekaly","year":"2008","journal-title":"J Exp Med"}],"container-title":["Psychosomatic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006842-200806000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:06:54Z","timestamp":1786036014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006842-200806000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/psy.0b013e31817ae69f","relation":{},"ISSN":["0033-3174"],"issn-type":[{"value":"0033-3174","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}